logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Intraocular Lens Associated Postoperative Inflammation

    FiltersReset Filters
    5 results

    • bromsite

      (bromfenac)
      Sun Pharmaceutical Industries, Inc.
      Usage: BromSite (bromfenac ophthalmic solution) 0.075% is indicated for treating postoperative inflammation and preventing ocular pain in patients who have undergone cataract surgery.

    • dexycu

      (dexamethasone)
      EyePoint Pharmaceuticals US, Inc
      Usage: DEXYCU (dexamethasone intraocular suspension) 9% is indicated for the treatment of postoperative inflammation following eye surgery.

    • ketorolac tromethamine

      (ketorolac tromethamine)
      SOLA Pharmaceuticals, LLC
      Usage: Ketorolac tromethamine ophthalmic solution is indicated for the temporary relief of ocular itching caused by seasonal allergic conjunctivitis and for treating postoperative inflammation in patients who have undergone cataract extraction.

    • ketorolac tromethamine

      (ketorolac tromethamine)
      Sandoz Inc
      Usage: Ketorolac tromethamine ophthalmic solution is indicated for temporary relief of ocular itching from seasonal allergic conjunctivitis and for treating postoperative inflammation following cataract extraction.

    • prolensa

      (Bromfenac Sodium)
      Bausch & Lomb Incorporated
      Usage: PROLENSA® (bromfenac ophthalmic solution) 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.